Skip to main content
Smart Investors Daily
CSPC Pharmaceutical Group Limited logo

NYSE · CSPCY

CSPC Pharmaceutical Group Limited

Healthcare · Drug Manufacturers - General

$3.94

Down-$0.17 (-4.21%)

Updated Nov 1, 2026, 12:48 AM

SID Score

5.9/10

Composite research score

Smart Money

46/100

Neutral

Market cap
11.3B
P/E ratio
18.57
Dividend yield
3.11%
52-week range
— – —
Volume
598
Avg. volume
37.17K

Price performance · CSPCY

CSPCY price history

1M range · 0 trading sessions · Daily adjusted prices

CSPCY does not have enough price history for the selected period.

Data unavailable

The requested market data was not found.

Latest CSPCY news

The latest Smart Investors Daily articles mentioning CSPCY.

CSPCY research

Overview

Company profile and research snapshot.

Company profile

CSPC PHARMS GRP U/ADR

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Oct 15, 2026

CSPC Pharmaceutical Group (SEHK:1093) Reports Encouraging SYS6002 Data, Is The Valuation Gap Still Open?

CSPC Pharmaceutical Group (SEHK:1093) has drawn fresh attention after presenting Phase I data for its Nectin-4 targeted antibody drug conjugate SYS6002 in advanced cervical cancer at IGCS2026, covering safety, tolerability and early response metrics. CSPC Pharmaceutical Group shares now trade at HK$8.865, with a 90 day share price return of 9.44% and a year to date share price gain of 4.54%. The 1 year total shareholder return is slightly down 0.73% despite a strong 76.74% total shareholder...

defenseworld.net · Dec 12, 2025

CSPC Pharmaceutical Group (OTCMKTS:CSPCY) Shares Down 0.5% – Here’s What Happened

CSPC Pharmaceutical Group Limited (OTCMKTS:CSPCY - Get Free Report)'s share price traded down 0.5% during trading on Thursday. The company traded as low as C$3.88 and last traded at C$3.91. 35,649 shares were traded during mid-day trading, an increase of 58% from the average session volume of 22,493 shares. The stock had previously closed

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.